In addition, although loss of heterozygosity was discovered in 41 ovarian cancer cell lines generally used in most laboratories, it was rare to find a complete loss of function caused by both of BRCA1 and BRCA2 mutations [28]. This evidence concerns the gene BRCA1 and ovarian cancer.